CD4 and neoplasm: To determine if there were additional cell types that contribute to the effect of αTIGIT and bintrafusp alfa combination treatment, MC38-CEA tumor bearing animals were depleted of CD4+, CD8+ and NK cells (gray line), which resulted in rapid tumor progression (Figure 3 b and e).